How many times are you going to watch a project blow up and say, โI shouldโve gotten in earlierโ? Injective Protocol was one of those rare projects that slipped through the cracks for a lot of early adopters. Its early-stage price was laughably low compared to where it stands nowโand those who caught the wave are chilling on massive profits. But if youโre still clinging to the regret of skipping out on Injectiveโs early momentum, thereโs no point in drowning in what-ifs. What you really need is a smart way forward, something fresh, promising, and on the brink of making waves in 2025. The market doesnโt pause for regretsโit rewards the ones who move before the crowd wakes up.